Identification of dopamine transporter in bovine pineal gland using [3H]GBR 12935

Journal of Pineal Research

Volumn 35, Issue 1, 2003, Pages 16-23

  Govitrapong, P ^a,b   Vilaipun, P ^b   Ebadi, Manuchair ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

D1 dopamine receptors; D2 dopamine receptors; Dopamine transporter; Melatonin; N acetyltransferase; Pineal gland

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMITRIPTYLINE; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; FLUOXETINE; FLUPENTIXOL; FLUVOXAMINE; IMIPRAMINE; NISOXETINE; NOMIFENSINE; NORADRENALIN; RADIOLIGAND; SEROTONIN; TRITIUM; VANOXERINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORPUS STRIATUM; DISSOCIATION; DRUG MECHANISM; EQUILIBRIUM CONSTANT; MEMBRANE BINDING; NONHUMAN; PHARMACOLOGICAL BLOCKING; PINEAL BODY; PREFRONTAL CORTEX; PROTEIN LOCALIZATION; SWINE; TISSUE DISTRIBUTION;

ANIMALS; CATTLE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; LIGANDS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; PINEAL GLAND; PIPERAZINES; TIME FACTORS; TRITIUM;

EID: 0038346724     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2003.00033.x     Document Type: Article

References (56)

1. EBADI M. Multiple pineal receptors in regulating melatonin synthesis. In: Melatonin, Biosynthesis, Physiological Effects, and Clinical Applications. Yu HS, Reiter RJ, eds., CRC Press, USA. 1993; pp. 39-71
2. 2-dopaminergic receptor agonists in the rat pineal glands in culture. J Pineal Res 1989; 6:17-31.
3. VOISON P, COLLIN JP. Regulation of chicken pineal arylalkylamine-N-acetyltransferase by postsynaptic alpha2-adrenergic receptors. Life Sci 1986; 39:2025-2032.
4. SAKAI Y, HIRA Y, MATSUSHIMA S. Regional differences in the pineal gland of the cotton rat, Sigmodon hispidus: light microscopic, electron microscopic, and immunohistochemical observations. J Pineal Res 1996; 20:125-137.
5. 3H] 23390. J Pharmacol Exp Ther 1990; 253:214-220.
6. 3H]dopamine released by different frequencies of stimulation from rabbit retina. Br J Pharmacol 1986; 88:51-61.
7. GOVITRAPONG P, MURRIN LC, EBADI M. Characterization of dopaminergic receptor sites in bovine pineal gland. J Pineal Res 1984; 1:215-226.
8. SIMONNEAUX V, HAPPE HK, EBADI M, MURRIN LC. Autoradiographic localization of dopaminergic and noradrenergic receptor in the bovine pineal gland. J Neurochem 1991; 57:1796-1802.
9. MOLLER M, RAVAULT JP, GOZZI B, ZHANG ET, PHANSUWAN-PUJITO P, LARSEN PJ, MIKKELSEN JD. The multineuronal input to the mammalian pineal gland. Adv Pineal Res 1991; 6:3-12.
10. IVERSEN LL. Uptake mechanisms for neurotransmitter amines. Biochem Pharmacol 1974; 23:1927-1935.
11. 3H]cocaine binding to the dopamine transporter in Parkinson's Disease. Eur J Pharmacol 1983; 95:145-146.
12. RITZ MC, LAMB RJ, GOLDBERG SR, KUHAR MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237:1219-1223.
13. 3H] WIN 35428. J Pharmacol Exp Ther 1991; 257:954-958.
14. - dependent like orphan transporter, Rxt 1, on synaptic vesicles in the rat central nervous system. Eur J Neurosci 1999; 1:1349-1361.
15. REITH EAM, Xu C, CHEN N. Pharmacology and regulation of the neuronal dopamine transporter. Eur J Pharmacol 1997; 324:1-10.
16. 3H]cocaine in striatum and its relationship to the dopamine transporter. Biochem 1998; 7:87-106.
17. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Naunyn-Schmiedeberg's Arch Pharmacol 1985; 329:227-235.
18. 3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 1989; 251:131-141.
19. 3H]mazindol J Pharmacol Exp Ther 1990; 253:1206-1214.
20. 3H]GBR 12935: a specific high affinity ligand for labeling the dopamine transporter complex. Eur J Pharmacol 1985; 107:289-290.
21. 3H]GBR 12935 binding in vivo in mouse brain labeling of a piperazine acceptor site. Eur J Pharmacol 1987; 144:1-6.
22. IZENWASSER S, WERLING LL, ROSENBERGER JG, COX BM. Characterization of binding of GBR 12935 (1-[2-(diphenyl-methexy)ethyl]-4-(3-phenylpropyl piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways. Neuro Pharmacol 1990; 29:1017-1024.
23. PAGE G, PEETERS M, MALOTEAUX JM, HERMANS E. Increased dopamine uptake in striatal synaptosomes after treatment of rat with amantadine. Eur J Pharmacol 2000; 403:75-80.
24. 3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol Pharmacol 1984; 26:35-44.
25. REITH MEA, MEISLER BH, SERSHEN H, LAJTHA A. Structural requirements for cocaine congeners to interact with dopamine and Serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 1986; 35:1123-1129.
26. 3H]nomifensine to striatal membranes. Biochem Pharmacol 1985; 34:1137-1144.
27. 3H]BTCP: a new phencyclidine analog selective for the dopamine uptake complex. Eur J Pharmacol 1988; 148:427-436.
28. 3H]Theo(±)-methylphenidate binding to 3,4-dihydroxy phenytethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid ester. J Neurochem 1985; 45:1062-1070.
29. 125I]RTI-55: a potent ligand for dopamine transporters. Eur J Pharmacol 1991; 194:133-134.
30. TARAZI FI, ZHANG K, BALDESSARINI RJ. Olanzapine, quetiapine, and risperidone: long-term effects on mono-amine transporters in rat forebrain. Neurosci Lett 2000; 287:81-84.
31. 3H]GBR 12935 binding in brain: a radioligand for selective labeling of the dopamine transport complex. J Neurochem 1986; 46:1272-1276.
32. 3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J Neurochem 1987; 48:1877-1896.
33. 3H]GBR 12935 binding to dopamine uptake sites in rat striatum. Neuro Psych Bio 1991; 23:177-81.
34. 3H]GBR 12935 binding to dopamine uptake sites in the human brain. Brain Res 1988; 457:122-129.
35. 3H]GBR 12935 binding to dopamine uptake sites in the human brain. J Neurochem 1989; 53:1400-1404.
36. 3H]GBR 12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's diseases. J Neurochem 1987; 49:17-21.
37. BRADFORD NM. A rapid and senitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
38. MUNSON PJ, RODBARD D. LIGAND: A versatile computerized approach for characterization of ligand-binding system. Anal Biochem 1980; 107:220-239.
39. 3H]GBR 12935: binding characteristics. Brain Res 1991; 540:1-13.
40. VAN DER ZEE H, MALIK AB, LEE BC, HAKIM TS. Lung fluid and protein exchange during intracranial hypertension and role of sympathetic mechanism. J Appl Physiol 1980; 48:273-280.
41. 3H]GBR 12935 binding to dopamine uptake sites: Subcellular localization and reduction in Parkinson's disease and progressive Supranuclear Palsy. Eur J Pharmacol 1988; 156:331-340.
42. 3H]GBR 12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics. JPN J Pharmacol 1988; 47:37-43.
43. 125I]RTI-55 to dopamine and Serotonin transporters in rat brain. Synapse 1992; 12:27-36.
44. 125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography. Synapse 1992; 12:37-44.
45. 3H]GBR 12935 binding to Cytochrome P450 in human brain. J Neurochem 1994; 62:342-348.
46. 3H]GBR 12935 binding in the human and rat frontal cortex. J Neurochem 1991; 56:1663-1672.
47. GUDEHITHLY KP, BHARGAVA HN. Modification of the characteristics of dopamine transporter in brain regions and spinal cord of morphine tolerant and abstinent rats. Neuropharmacology 1996; 35:169-174.
48. 3H]GBR 12935 binding proteins. Arch Biochem Biophys 1990; 276:424-432.
49. AMARA SG, KUHAR MJ. Neurotransmitter transporters: Recent progress. Annu Rev Neurosci 1993; 16:73-93.
50. RUDNICK G. Mechanisms of biogenic amine neurotransmitter transporters. In: Neurotransmitter Transporters: Structure Function, Regulation. REITH MEA, ed., Human Press, Totowa, NJ, 1997; pp. 73-100.
51. DEUTCH AY, TAM SY, FREEMAN AS, BOWERS MB, ROTH RH Jr. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Eur J Pharmacol 1987; 134:257-264.
52. 14-metatonin synthesis in rat pineal in organ culture. Proc Natl Sci USA. 1969; 62:544-549.
53. DEGUCHI T, AXELROD J. Control of circadian change in Serotonin N-acetyltransferase activity in the pineal organ by the beta-adrenergic receptor. Pro Natl Acad Sci 1972; 69:2547-2550.
54. LEW R, VAUGHAU R, SIMANTOV R, WILSON A, KUHAR MJ. Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weight. Synapse 1991; 8:152-153.
55. MARSHELL JF, O'DELL SJ, NAVARRETE R, ROSENSTEIN AJ. Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Neuroscience 1990; 37:11-21.
56. JIN KL, SHIOTANI Y, KAWAI Y, KIYAMA H. Immunohistochemical demonstration of tyrosine hydroxytase (TH)-positive but dopamine beta-hydroxylase (DBH)-negative neuron-like cells in the pineal gland of golden hamsters. Neurosci Lett 1988; 93:28-31.